KR102705507B1 - 염증성 피부 상태를 치료하기 위한 미노사이클린 - Google Patents

염증성 피부 상태를 치료하기 위한 미노사이클린 Download PDF

Info

Publication number
KR102705507B1
KR102705507B1 KR1020207022760A KR20207022760A KR102705507B1 KR 102705507 B1 KR102705507 B1 KR 102705507B1 KR 1020207022760 A KR1020207022760 A KR 1020207022760A KR 20207022760 A KR20207022760 A KR 20207022760A KR 102705507 B1 KR102705507 B1 KR 102705507B1
Authority
KR
South Korea
Prior art keywords
minocycline
pharmaceutical composition
composition
delete delete
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207022760A
Other languages
English (en)
Korean (ko)
Other versions
KR20200108018A (ko
Inventor
스와티 쿨카르니
비자이 쿠마르 파드히
샤바스 알리쿤주
라지이브 싱 라그후반시
스리니바스 람찬드라 시드기디
아니루드 가우탐
Original Assignee
닥터 레디스 레보러터리즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65269058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102705507(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 닥터 레디스 레보러터리즈 리미티드 filed Critical 닥터 레디스 레보러터리즈 리미티드
Publication of KR20200108018A publication Critical patent/KR20200108018A/ko
Application granted granted Critical
Publication of KR102705507B1 publication Critical patent/KR102705507B1/ko
Assigned to 저니 메디컬 코퍼레이션 reassignment 저니 메디컬 코퍼레이션 권리의 전부이전등록 Assignors: 닥터 레디스 레보러터리즈 리미티드
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020207022760A 2018-01-07 2019-01-07 염증성 피부 상태를 치료하기 위한 미노사이클린 Active KR102705507B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201741023993 2018-01-07
IN201741023993 2018-01-07
PCT/IB2019/000144 WO2019135166A1 (en) 2018-01-07 2019-01-07 Minocycline for treating inflammatory skin conditions

Publications (2)

Publication Number Publication Date
KR20200108018A KR20200108018A (ko) 2020-09-16
KR102705507B1 true KR102705507B1 (ko) 2024-09-10

Family

ID=65269058

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207022760A Active KR102705507B1 (ko) 2018-01-07 2019-01-07 염증성 피부 상태를 치료하기 위한 미노사이클린

Country Status (11)

Country Link
US (4) US11191740B2 (https=)
EP (1) EP3735249A1 (https=)
JP (3) JP7561029B2 (https=)
KR (1) KR102705507B1 (https=)
CN (1) CN111818927A (https=)
AU (2) AU2019205134B9 (https=)
BR (1) BR112020013789A2 (https=)
CA (1) CA3087838A1 (https=)
EA (1) EA202091653A1 (https=)
MX (1) MX2020007222A (https=)
WO (1) WO2019135166A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン
CA3106884C (en) * 2018-07-19 2025-04-01 Doosan Bobcat North America, Inc. DISPLAY POSITION FOR CABIN WITH TILTING DOOR
CN120324439A (zh) * 2025-03-05 2025-07-18 福安药业集团宁波天衡制药有限公司 一种稳定的盐酸米诺环素胶囊及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041846A1 (en) * 2005-06-24 2009-02-12 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1383508B1 (en) * 2001-04-05 2006-06-21 Collagenex Pharmaceuticals, Inc. Doxycycline for the treatment of acne
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20140186269A1 (en) 2013-01-03 2014-07-03 Foamix Ltd. Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041846A1 (en) * 2005-06-24 2009-02-12 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne

Also Published As

Publication number Publication date
EA202091653A1 (ru) 2020-12-23
CA3087838A1 (en) 2019-07-11
WO2019135166A9 (en) 2020-07-16
AU2019205134A1 (en) 2020-08-20
US10905664B2 (en) 2021-02-02
AU2019205134B2 (en) 2024-11-07
RU2020125984A3 (https=) 2022-02-07
US12594252B2 (en) 2026-04-07
KR20200108018A (ko) 2020-09-16
BR112020013789A2 (pt) 2021-02-17
JP2026031656A (ja) 2026-02-24
JP2021509409A (ja) 2021-03-25
US20200222345A1 (en) 2020-07-16
RU2020125984A (ru) 2022-02-07
AU2019205134A2 (en) 2020-08-20
EP3735249A1 (en) 2020-11-11
US11191740B2 (en) 2021-12-07
AU2019205134B9 (en) 2025-02-20
JP7561029B2 (ja) 2024-10-03
JP2024098011A (ja) 2024-07-19
US20190209500A1 (en) 2019-07-11
WO2019135166A1 (en) 2019-07-11
CN111818927A (zh) 2020-10-23
US20210121420A1 (en) 2021-04-29
MX2020007222A (es) 2020-12-10
US11364212B2 (en) 2022-06-21
AU2025200826A1 (en) 2025-02-27
US20230131030A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
KR101784777B1 (ko) 타펜타돌 조성물
US12594252B2 (en) Methods for treating inflammatory skin conditions
WO2009034541A2 (en) Controlled release pharmaceutical dosage forms of trimetazidine
KR20210147082A (ko) 디메틸푸마레이트를 포함하는 일일 저용량 투여용 약제학적 조성물
US20220031714A1 (en) Modified release doxycycline composition
RU2787528C2 (ru) Миноциклин для лечения воспалительных заболеваний кожи
HK40039196A (en) Minocycline for treating inflammatory skin conditions
EA045615B1 (ru) Миноциклин для лечения воспалительных заболеваний кожи
US20110195121A1 (en) chronotherapeutic pharmaceutical dosage form
TWI743059B (zh) 二氟甲基鳥氨酸及舒林酸（ｓｕｌｉｎｄａｃ），固定劑量組合調配物
JP2021120397A (ja) 低１日用量で投与するためのフマル酸ジメチルを含む医薬組成物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

R14 Transfer of ownership recorded

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R14-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)